-
Module 2_BCMA-Targeted CAR T-cells
24:20
-
Module 1_Introduction and Rationale for Targeting BCMA on MM Cells
10:45
-
Module 3_BCMA-Targeted Antibody-Drug Conjugates (ADCs)
9:40
-
Module 4_BCMA-Targeted Bispecifics
22:12
-
Virtual Challenging Case Clinic: Multiple Myeloma_Updates from ASH_Peter Voorhees, MD
56:33
-
Virtual Challenging Case Clinic: Multiple Myeloma_Optimal Induction and Maintenance Therapies_Amrita Krishnan, MD
47:14
-
New Approvals and Advanced Targets in MM_Joshua Richter, MD
49:01
-
Madhav Dhodapkar, MBBS; Emory University Winship Cancer Institute; #DDHO2022
12:52
-
Sagar Lonial, MD, FACP; Emory University Winship Cancer Institute; #DDHO2022
23:12
-
Jonathan Kaufman, MD; Emory University Winship Cancer Institute; #DDHO2022
17:41
-
Craig Hofmeister, MD, MPH; Emory University Winship Cancer Institute; #DDHO2022
10:06
- Next Page